Jensen; Knud J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jensen; Knud J..The latest application filed is for "p3 peptidylic inhibitors for treating cag-repeat rna toxicity in polyglutamine diseases".
- Jensen; Knud J. - Copenhagen DK
- Jensen; Knud J. - Copenhagen N DK
- Jensen; Knud J. - Minneapolis MN
| Patent | Date |
|---|---|
| P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases Grant 10,570,177 - Chan , et al. Feb | 2020-02-25 |
| P3 Peptidylic Inhibitors For Treating Cag-repeat Rna Toxicity In Polyglutamine Diseases App 20180251493 - CHAN; Ho Yin Edwin ; et al. | 2018-09-06 |
| Human insulin analogues and derivatives comprising cysteine substitutions Grant 9,187,547 - Vinther , et al. November 17, 2 | 2015-11-17 |
| Human Insulin Analogues and Derivatives Comprising Cysteine Substitutions App 20140031279 - Vinther; Tine Nygaard ; et al. | 2014-01-30 |
| Solid-phase synthesis of oligosaccharides and glycopeptides using glycosynthases App 20030138880 - Withers, Stephen G. ; et al. | 2003-07-24 |
| Support material for solid phase organic synthesis Grant 5,917,015 - Jensen , et al. June 29, 1 | 1999-06-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 